Attached files

file filename
10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Allergan plcd171146d10ka.htm
EX-31.2 - EX-31.2 - Allergan plcd171146dex312.htm
EX-21.1 - EX-21.1 - Allergan plcd171146dex211.htm

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Rule 13a-14(a) Under the Securities Exchange Act of 1934

I, Brenton L. Saunders, President and Chief Executive Officer, certify that:

1. I have reviewed this annual report on Form 10-K/A of Allergan plc and Warner Chilcott Limited; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: April 4, 2016

 

By:  

/s/    BRENTON L. SAUNDERS        

  Brenton L. Saunders
  President and Chief Executive Officer
  (Principal Executive Officer)